Jane Street
AQST icon

Jane Street’s Aquestive Therapeutics AQST Stock Holding History

Jane Street’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.8K Sell
19,000
-4,800
-20% -$19.5K ﹤0.01% 10754
2025
Q4 		$154K Buy
+23,800
New +$148K ﹤0.01% 9912

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street's AQST Position: Q1 2026 in Review

Jane Street increased its Aquestive Therapeutics (AQST) stake by 101% in Q1 2026, buying an estimated $2.1M and bringing the position to 1,030,050 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3736.

Jane Street first reported a position in AQST in Q2 2019 and has held it in 16 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Jane Street held 1,030,050 shares of Aquestive Therapeutics worth $4.27M as of Q1 2026.
  • Jane Street bought 517,830 Aquestive Therapeutics shares in Q1 2026, an estimated $2.1M.
  • Aquestive Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3736 holding.
  • Jane Street first reported a position in Aquestive Therapeutics in Q2 2019 and has held it in 16 quarters since.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.